Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2026-04-09 17:25:08 ET · period of report 2026-04-08 · accession 0001213900-26-042079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-09 17:25 | 2026-04-08 | TARA | Zummo Jacqueline | Chief R, D Off | S - Sale | $5.40 | -1,134 | 94.8K | -1% | -$6,124 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-08 | S | D | 1,134 | $5.40 | 94,827 | D | — | — | (F1) The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 31, 2025. |